We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Ultrasound Technology Designed to Enhance Diagnostics in Europe

By MedImaging International staff writers
Posted on 02 Jun 2010
Print article
Radiation standards are becoming increasingly strict in European hospitals. Ultrasound, however, has an advantage over radioactive applications with regard to patient safety.

Ultrasound is nonradioactive, and manufacturers are trying to improve its flexibility in both primary and secondary diagnosis. Moreover, several medical research universities are gathering data on individual organ physiology and function, paving the way for therapeutic ultrasound. Smaller companies are also moving into developing organ-specific therapeutic ultrasound solutions due to their non-invasive treatment.

New market research from Frost & Sullivan (Palo Alto, CA, USA), an international medical consultancy company, revealed that the market earned revenues of US$371.0 million in 2008, and estimates this to reach $438.0 million in 2015. The technologies covered in this research service are three-dimensional (3D) and four-dimensional (4D) imaging, contrast media, and elastography.

"Although the ultrasound market in Europe is saturated and is a replacement market, stable growth is projected in the therapeutic and contrast-enhanced ultrasound segment,” says Frost & Sullivan research analyst Shriram Shanmugham. "While clinical research is becoming more intensive, the research facilities and ultrasound companies are forming associations to accelerate its development.”

Therapeutic ultrasound procedures are not only nonradioactive but also noninvasive, and have a faster patient recovery time. However, the economic downturn has forced many hospitals to slash costs by either delaying their investments in the purchase of medical equipment or opting for used and refurbished systems. Any savings are used to maintain hospital productivity. "Purchasing used and refurbished systems are a priority for hospitals that have budgetary constraints for new medical equipments,” explained Mr. Shanmugham. "Additionally, some hospitals are postponing their equipment purchase to the next fiscal year, further impeding the purchase of new equipment.”

Ultrasound manufacturers should emphasize the significance of purchasing latest equipment. They should provide a concise portfolio of the transitions expected with ultrasound technology and convince hospitals to consider long-term investments, according to Frost & Sullivan analysts.

"Enhancing customer interaction will be the key for manufacturers, especially now, when the economy is in a slump,” concluded Mr. Shanmugham. "Manufacturers should promote specialized programs that accentuate customer involvement, ensuring customer loyalty in the long-term.”

Related Links:
Frost & Sullivan


Portable Color Doppler Ultrasound Scanner
DCU10
Ultra-Flat DR Detector
meX+1717SCC
New
Medical Radiographic X-Ray Machine
TR30N HF
Portable X-ray Unit
AJEX140H

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.